| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 7.841 | 32.986 | 29.946 | 38.552 | 34.071 | 33.386 | 54.662 |
| Total Income - EUR | - | - | - | 7.841 | 32.986 | 29.946 | 38.554 | 34.076 | 33.392 | 54.665 |
| Total Expenses - EUR | - | - | - | 3.313 | 12.469 | 13.751 | 14.509 | 15.572 | 17.367 | 25.457 |
| Gross Profit/Loss - EUR | - | - | - | 4.527 | 20.518 | 16.195 | 24.045 | 18.504 | 16.026 | 29.209 |
| Net Profit/Loss - EUR | - | - | - | 4.448 | 20.188 | 15.918 | 23.660 | 18.163 | 15.692 | 27.569 |
| Employees | - | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Urogyndr S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 9.105 | 8.081 | 6.329 | 4.903 | 4.210 |
| Current Assets | - | - | - | 5.399 | 25.443 | 7.741 | 18.204 | 24.718 | 13.311 | 29.276 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 183 | 91 | 455 | 505 | 15.174 | 1.441 | 16.095 |
| Cash | - | - | - | 5.216 | 25.351 | 7.287 | 17.698 | 9.545 | 11.870 | 13.181 |
| Shareholders Funds | - | - | - | 4.491 | 24.592 | 15.968 | 23.708 | 18.212 | 15.740 | 27.617 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 908 | 851 | 878 | 2.576 | 12.836 | 2.473 | 5.869 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Urogyndr S.r.l.